Y Intercept (Hong Kong) LTD Xeris Biopharma Holdings, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.83 Billion
- Q3 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 82,181 shares of XERS stock, worth $802,086. This represents 0.02% of its overall portfolio holdings.
Number of Shares
82,181
Previous 336,214
75.56%
Holding current value
$802,086
Previous $1.57 Million
57.64%
% of portfolio
0.02%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
214Shares Held
90.1MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$95.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$37.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$36.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$35.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.33B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...